Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05910697 · ClinicalTrials.gov registry record · NA
Clinical Utility of MyProstateScore 2.0 P2
A NA study, sponsored by Qure Healthcare.
- Terminated
- Registry status
- NA
- Development phase
- 142
- Enrollment target
NCT05910697 is a NA study that was terminated before completion, run by Qure Healthcare. The registered enrollment target is 142 participants.
The verdict
NCT05910697, a NA study, was terminated before completion, sponsored by Qure Healthcare.
- TERMINATED
- Registry status
- NA
- Development phase
- 142 participants
- Enrollment target
Study Summary
This is an extension of an ongoing study. Preliminary results from the ongoing study indicate that the MyProstateScore 2.0 (MPS 2.0) Test is significantly improving early diagnosis of prostate cancer. This extension will allow us to ask the study participants in the ongoing study to share patient-level data for chart abstraction. The specific purpose of this study is to generate high-quality real-world data on the clinical utility of LynxDx's new MPS 2.0 test.
Interventions
- OTHER MyProstateScore 2.0 Results
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 142 participants |
| Start Date | 2023-03-31 |
| Est. Completion | 2023-10-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05910697
The ClinicalTrials.gov registry entry for NCT05910697 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 142 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Qure Healthcare, which has 21 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MyProstateScore 2.0 Results is the first listed.
NCT05910697 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05910697 about?
NCT05910697 is a clinical study titled "Clinical Utility of MyProstateScore 2.0 P2". This is an extension of an ongoing study. Preliminary results from the ongoing study indicate that the MyProstateScore 2.0 (MPS 2.0) Test is significantly improving early diagnosis of prostate cancer. This extension will allow us to ask the study participants in the ongoing study to share patient-le...
What is the current status of trial NCT05910697?
This trial is currently terminated. It is a NA study. The enrollment target is 142 participants. The study started on 2023-03-31. Estimated completion is 2023-10-18.
What interventions are being tested in trial NCT05910697?
The interventions under investigation include: MyProstateScore 2.0 Results (OTHER).
Who is sponsoring clinical trial NCT05910697?
This trial is sponsored by Qure Healthcare, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.